Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2015 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors...
February 26, 2015 16:04 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Corporate Update

Global Net Product Sales for PROCYSBI® of $69.5 Million for 2014 2015 PROCYSBI Revenue Guidance of $80-$90 Million Company to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30...
February 23, 2015 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Observe International Rare Disease Day Through Global Awareness Programs

NOVATO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its support of Rare Disease Day on February 28, 2015 with a series of initiatives and events...
February 18, 2015 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Attend Upcoming Investor Conferences

NOVATO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that Michael Smith, Chief Financial Officer will participate in the following investor...
February 17, 2015 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Thursday, February 26, 2015 at 4:30 p.m. ET

NOVATO, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release fourth quarter and full year 2014 financial results on...
February 10, 2015 09:51 ET | Source: Raptor Pharmaceutical Inc

PROCYSBI(R) to Receive New Treatment Award From Lysosomal Disease Network at the 11th Annual WORLD Symposium

NOVATO, Calif., Feb. 10, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the Lysosomal Disease Network (LDN) will present Raptor Pharmaceutical with the 2015...
January 30, 2015 13:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical to Present at the 2015 Leerink Global Healthcare Conference

NOVATO, Calif., Jan. 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference: Julie Anne Smith, President and Chief...
January 20, 2015 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on January 15, 2015, a majority of the independent members of the Company's Board of...
January 07, 2015 08:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer

NOVATO, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Krishna R. Polu, M.D., as its Chief Medical Officer and Michael P. Smith...
December 18, 2014 07:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Appoints Gregg Lapointe and Georges Gemayel to Board of Directors

NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors,...